Related Experiment Video
Updated: Jun 16, 2026

07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Advances in penile cancer management.
José Roberto Rossari1, Tushar Vora, Thierry Gil
1Institute Jules Bordet, Brussels, Belgium.
Current Opinion in Oncology
|February 13, 2010
Summary
This review highlights recent advancements in penile cancer management, focusing on less invasive treatments and improved quality of life. Further multicenter studies are needed to refine these approaches for better patient outcomes.
Area of Science:
- Oncology
- Urology
Background:
- Penile cancer significantly impacts patients physically and psychologically.
- Minimizing treatment invasiveness and morbidity is crucial for organ function preservation and disease control.
Purpose of the Study:
- To review recent advancements in penile cancer management.
- To focus on data published in the last few years regarding therapeutic approaches.
Main Methods:
- Review of recent scientific literature on penile cancer management.
- Analysis of new diagnostic and therapeutic techniques.
- Evaluation of quality of life and psychosexual impact.
Main Results:
- Updated TNM staging and follow-up schedules based on disease natural history.
- Application of modern imaging and gene profiling.
- Increased experience with sentinel lymph node biopsy and radiotherapy.
- Development of new penile cancer guidelines.
Conclusions:
- New diagnostic and therapeutic techniques are emerging.
- Identifying patients suitable for less invasive treatments requires further study.
- Collaborative multicenter studies are essential for advancing penile cancer care.
Related Concept Videos
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
